Anifrolumab (Saphnelo) lowered the risk of long-term organ damage progression by about 60% The drug received federal approval in 2021 WEDNESDAY, Feb. 19, 2025 (HealthDay News) -- Lupus can do ...
Lupus 7(2), 80-85 (1998). Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License ...
Nine's Wide World of Sports on MSN7h
Hooper, Manu splurges can't save big spending club
Michael Hooper celebrated scoring his first try since coming out of retirement but his star-studded Toyota Verblitz team continues to struggle in Japan.
“There are also some studies that show that red light may help to restore hair for those with male or female patterned hair ...
Glaxo (GSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Artificial intelligence specialist Owkin has added another piece to its medical research portfolio with the launch of ...
March began with Oscar pre-parties followed by the big show at the Dolby Theatre in Hollywood. Winners, including Mikey ...
Strength is in numbers and the same goes for fundraising which is why a charity has set up a scheme to encourage 1,000 people ...
Leerink Partners 2025 Global Healthcare Conference Call March 12, 2025 11:20 AM ETCompany ParticipantsRoland Chen ...
The program also covers three immunology and inflammation (I&I) areas—ulcerative colitis (UC), Crohn's disease (CD), and systemic lupus erythematosus (SLE)—as well as Alzheimer's disease (AD) in ...